The false myths about generic medicines

July 24, 2015

Generic medicines are highly accepted by the population in many countries of the European Union. In countries such as Germany and UK the rate of generic drugs exceeds the 60% over the total consumed drugs.

Even though, there is still a lot to be done in order to overcome the myths that surrounded the generic drugs:

1- Generic drugs are less effective than the original ones

In markets such as the EU or USA, in order to get the approval from the authorities it is mandatory to prove by bioequivalence studies that the generic drug has the same efficacy and security than the original drug. These studies are done with humans and they certify that the medicine has the same performance once it is taken. In countries where the Bioequivalence studies are not a requirement, it is important for the population to ensure that generics have the Bioequivalence certification.

2- Less quality

In Europe, the laboratories that produce generic drugs have the same quality standards than the ones that produce innovative drugs. Besides this, there are some laboratories that manufacture in the same installations generic drugs and innovative drugs.

3- Retarded therapeutic effect

False, the bioequivalence studies prove that the blood concentration of active substance at each time is equal in the original drug and the generic one.

4- Generics can be difficult to identify

Some countries are working in order to differentiate generics from the innovative drug or other generics that are not bioequivalents. For example, nowadays in Chile it’s mandatory for bioequivalent generics to be identified by a yellow strip with the bioequivalence logo.

5- It exists a generic version of each medicine

False, original drugs are protected by patent. Once these expired then other pharmaceutical companies can develop the product.

B Bioequivalente